Annals of dermatology · 2024
Survey on Alopecia Areata Patients' Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kim Jung Eun, Lee Subin, Kang Hoon, Lee Young, Kim Do-Young, Park Hyunsun, Shin Hyun-Tae, Jang Yong Hyun, Shin Kihyuk, Lee Ji Hae, Choi Jee Woong, Park Byung Choel, Kim Beom Joon, Seo Soo Hong, Won Chong Hyun, Park Jin, Kim Min Sung, Kim Sang Seok, Lew Bark-Lynn, Huh Chang-Hun, Kwon Ohsang, Lee Yang Won, Kim Moon-Bum, Korean Hair Research Society
Аннотация
BACKGROUND: Alopecia areata (AA) is characterized by hair loss on the scalp and body, significantly impacting patients' quality of life based on its severity.
OBJECTIVE: This study aims to identify crucial factors influencing the perception of severe AA from the patients' viewpoint.
METHODS: A web-based survey was conducted among AA patients attending dermatology departments at 21 university hospitals in Korea. The survey comprised 17 criteria, exploring both clinical characteristics of AA patients and subjective determinants of disease severity.
RESULTS: A total of 791 AA patients and their caregivers participated in the survey. Approximately 30% of respondents developed AA during childhood, with 43.5% experiencing chronic courses lasting over 3 years. Half of the participants exhibited more than 20% scalp hair loss, and 42% reported additional hair loss on other body parts, such as eyelashes and nose hair. Most respondents agreed that patients with ≥20% scalp hair loss should be categorized as having severe AA. They also identified longer disease duration, involvement of non-scalp body hair, treatment refractoriness, and social or mental impairment requiring medical intervention as factors indicating increased disease severity.
CONCLUSION: This survey underscores the significant impact of AA on patients' quality of life and highlights existing unmet needs in current treatment modalities.
OBJECTIVE: This study aims to identify crucial factors influencing the perception of severe AA from the patients' viewpoint.
METHODS: A web-based survey was conducted among AA patients attending dermatology departments at 21 university hospitals in Korea. The survey comprised 17 criteria, exploring both clinical characteristics of AA patients and subjective determinants of disease severity.
RESULTS: A total of 791 AA patients and their caregivers participated in the survey. Approximately 30% of respondents developed AA during childhood, with 43.5% experiencing chronic courses lasting over 3 years. Half of the participants exhibited more than 20% scalp hair loss, and 42% reported additional hair loss on other body parts, such as eyelashes and nose hair. Most respondents agreed that patients with ≥20% scalp hair loss should be categorized as having severe AA. They also identified longer disease duration, involvement of non-scalp body hair, treatment refractoriness, and social or mental impairment requiring medical intervention as factors indicating increased disease severity.
CONCLUSION: This survey underscores the significant impact of AA on patients' quality of life and highlights existing unmet needs in current treatment modalities.